Clik here to view.
Labco
Nature de l'opération: Participation Date d'entrée: 2009 Labco is the leading pan European medical diagnostics network.The network includes more than 300 laboratories operated by close to 4,000...
View ArticleClik here to view.
Labco
Nature de l'opération: Participation Date d'entrée: 2009 Labco is the leading pan European medical diagnostics network.The network includes more than 300 laboratories operated by close to 4,000...
View ArticleClik here to view.
EA Pharma
Nature de l'opération: Participation Date d'entrée: 2009 Formed from the merger in 2006 between Laboratoire des Granions (Monaco) and Equilibre Attitude (Alpes Maritimes), the Group designs and...
View ArticleClik here to view.
Dynaction
Nature de l'opération: Participation Date d'entrée: 2000 Dynaction is an industrial holding company that has focused on just one area of development since late December 2005: Speciality Fine...
View ArticleClik here to view.
Vivalto Santé
Nature de l'opération: Participation Date d'entrée: 2009 Market leader in private clinics in Brittany (France), Vivalto Santé owns three care homes in the region ranked among the best in France, in...
View ArticleClik here to view.
Amakem
Nature de l'opération: Participation Date d'entrée: 2011 Founded in 2010, Amakem is an ophthalmology company developing new treatments for serious eye conditions. Amakem’s product pipeline is based...
View ArticleClik here to view.
Ameos
Nature de l'opération: Participation Date d'entrée: 2012 Headquartered in Zurich, Ameos was founded in 2002 by Dr Axel Paeger and German private equity firm Quadriga Capital. The group is the fifth...
View ArticleClik here to view.
Enterome
Nature de l'opération: Participation Date d'entrée: 2012 Based in Paris, Enterome is a medicine company dedicated to the identification and development of drugs and biomarkers based on altered gut...
View ArticleClik here to view.
Pixium
Nature de l'opération: Participation Date d'entrée: 2012 Created in 2011 and based in Paris, Pixium is specialized in the development of next generation retinal implants to treat blindness caused by...
View Article